CHF Flashcards
1
Q
number of americans with CHF
A
- 5 million
- most frequent medicare primary discharge diagnosis
2
Q
prevalence of CHF in AA population
A
25% higher than whites
-greater portion of risk attributable to modifiable factors
3
Q
CHF stats
A
- HTN doubles risk
- pts with NYHA class 4 HF have 50% 1 yr mortality
- 5 yr survival is 25% in men and 38% in women
4
Q
pathogenesis of CHF
A
- MISMATCH BETWEEN OUTPUT AND NEED
- mismatch could happen because there isnt enough volume in the ventricle (diastolic HF) or the ventricle is unable to overcome the pressure in the system (systolic HF)
1. myocardial hypertrophy
2. increased sympathetic activity
3. fluid retention
5
Q
pressure overload
A
elevated systolic BP
-forces heart to overcome excess pressure
6
Q
volume overload
A
increased diastolic volume
-causing dilation of the ventricle
7
Q
MCC CHF
A
- diabetes and coronary disease
- HTN and valve disease
8
Q
myocardial hypertrophy
A
- heart size increases and the chambers dilate
- heart muscle stretches: stronger contraction initially
- excessive elongation of the fibers results in weaker contractions - eventually you pull too far and you can’t generate any tension at all
- NORMAL MYOCARDIAL CELLS HYPERTROPHY TO MAINTAIN CONTRACTILE FORCE
- increases myocardial oxygen consumption because muscle is bigger and needs more food
9
Q
characteristics of hypertrophic myocardium
A
- slowed contraction time
- increased time to develop maximum tension
- delayed relaxation
- ultimately constricts chamber cells
10
Q
increased sympathetic activity in CHF
A
- activation of beta-adrenergic receptors in the heart: increased HR (tachy), greater force of contraction of heart muscle
- vasoconstriction enhances venous return and increases cardiac output
- decreased diastolic filling time
11
Q
RAAS activation in CHF
A
- decreased CO means the kidneys think blood volume is decreased
- release renin etc. to retain sodium and water
12
Q
effect of angio II on the heart
A
- CARDIOTOXIC!!
- causes cardiac hypertrophy and ventricular remodeling
13
Q
Vasodilator peptides
A
- Atrial natriuretic peptide (ANP)
- Brain natriuretic peptide (BNP): released by dilated heart by stimulation of stretch receptors
- elevated BNP correlates with more severe HF and poorer prognosis
14
Q
Effect of ANP and BNP
A
- diuresis of fluid and sodium
- decreased vascular resistance
- decreased renin/angio/aldo
15
Q
underlying causes of CHF
A
- myocardial injury: MI, ischemia, cardiomyopathy, myocarditis
- ischemic heart dz/CAD (DM) causes 75% of all CHF
- HTN
- Valvular heart dz